SCHEMBL27979862

SCHEMBL27979862

O=Cc1cc2c3ccccc3n(Cc3cccc(Cl)c3)c2cn1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.55
MEN1 O00255 1/20 0.55
USP2 O75604 1/20 0.55
MAPT P10636 4/20 0.52
ALDH1A1 P00352 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
MAPK10 P53779 1/20 0.50
TP53 P04637 2/20 0.47
CYP19A1 P11511 1/20 0.46
POLB P06746 6/20 0.43
DNM1 Q05193 1/20 0.43
CCR2 P41597 1/20 0.43
P2RX4 Q99571 1/20 0.42
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27979723 0.90 CYP19A1 (0.57) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL27979925 0.83 LMNA (0.54) KMT2AMEN1ALDH1A1TP53CYP19A1
SCHEMBL6220883 0.83 VDR (0.43) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL27979859 0.82 KMT2A (0.55) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL28179557 0.81 CYP19A1 (0.69) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL30616073 0.81 CYP19A1 (0.69) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL28179541 0.81 MAPT (0.56) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL27899802 0.81 MAPT (0.54) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL28813847 0.80 KMT2A (0.53) KMT2AMEN1USP2MAPTALDH1A1
SCHEMBL30583112 0.79 MEN1 (0.54) KMT2AMEN1USP2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104177377-B 3-diamine β -carboline alkali compound, preparation method thereof, pharmaceutical composition thereof and application thereof 新疆华世丹药物研究有限责任公司 2020-04-10 CN disclosed
CN-104177377-A 3-Position diamine beta-carboline alkali compound, and preparation method, medicinal composition and use thereof XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTD 2014-12-03 CN disclosed